A properly selected telehealth system can provide an effective format for healthcare delivery absent an in-person visit. Physicians are advised to consider a number of factors when determining if telehealth technology will benefit their practice and patients.
The U.S. Food and Drug Administration is evaluating the potential impact of SARS-CoV-2 viral mutations on authorized molecular tests.
On March 24, MLMIC and HANYS will host “Beyond the Behavioral Health Unit: Managing Mental Health.” This webinar will outline strategies for meeting the mental health needs of patients in the emergency department, the general inpatient unit and the ambulatory care setting
There are key factors to consider when determining whether a telehealth encounter is the right choice for an individual patient.